Skip to Main Content

3,036

Views

3

CrossRef citations to date

0

Altmetric

Articles

Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States

Richard T. Maziarza Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR, USA;b Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USACorrespondence[email protected]
View further author information

,

Hongbo Yangc Analysis Group, Inc., Boston, MA, USAView further author information

,

Qing Liuc Analysis Group, Inc., Boston, MA, USAView further author information

,

Travis Wangc Analysis Group, Inc., Boston, MA, USAView further author information

,

Jing Zhaoc Analysis Group, Inc., Boston, MA, USAView further author information

,

Stephen Limd Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information

,

Soyon Leed Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

https://orcid.org/0000-0002-2059-717X View further author information

,

Anand Dalald Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information

&

Vamsi Bollud Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information